• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Roadmap to personalized medicine.个性化医疗路线图。
Croat Med J. 2012 Aug;53(4):294-7. doi: 10.3325/cmj.2012.53.294.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
A research roadmap for complementary and alternative medicine - what we need to know by 2020.补充和替代医学研究路线图——到2020年我们需要了解的内容。
Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.
4
Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.肿瘤控制——个性化癌症医学中心:卫生技术评估与结果研究的方法及应用
Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):330-40. doi: 10.1016/j.zefq.2015.06.012. Epub 2015 Jul 28.
5
Nanotechnology: an evidence-based analysis.纳米技术:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 1.
6
Going MAD: development of a "matrix academic division" to facilitate translating research to personalized medicine.走向疯狂:建立“矩阵学术分工”以促进研究向个体化医学转化。
Acad Med. 2011 Nov;86(11):1353-9. doi: 10.1097/ACM.0b013e3182303d7a.
7
The project data sphere initiative: accelerating cancer research by sharing data.项目数据领域计划:通过数据共享加速癌症研究
Oncologist. 2015 May;20(5):464-e20. doi: 10.1634/theoncologist.2014-0431. Epub 2015 Apr 15.
8
Tuberculosis结核病
9
Problems, challenges and promises: perspectives on precision medicine.问题、挑战与前景:精准医学的视角
Brief Bioinform. 2016 May;17(3):494-504. doi: 10.1093/bib/bbv060. Epub 2015 Aug 5.
10
An integrated framework of personalized medicine: from individual genomes to participatory health care.个性化医疗的综合框架:从个体基因组到参与式医疗保健。
Croat Med J. 2012 Aug;53(4):301-3. doi: 10.3325/cmj.2012.53.301.

引用本文的文献

1
Chronological Analysis of First-in-Class Drugs Approved from 2011 to 2022: Their Technological Trend and Origin.2011年至2022年批准的首创药物的时间顺序分析:其技术趋势与起源
Pharmaceutics. 2023 Jun 22;15(7):1794. doi: 10.3390/pharmaceutics15071794.
2
Perceptions and factors affecting pharmaceutical market access: results from a literature review and survey of stakeholders in different settings.影响药品市场准入的认知与因素:文献综述及不同环境下利益相关者调查的结果
J Mark Access Health Policy. 2016 Sep 27;4. doi: 10.3402/jmahp.v4.31660. eCollection 2016.
3
Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.第三届年度深部脑刺激智囊团会议论文集:新兴问题与技术综述
Front Neurosci. 2016 Apr 6;10:119. doi: 10.3389/fnins.2016.00119. eCollection 2016.
4
EPMA position paper in cancer: current overview and future perspectives.电子探针微量分析在癌症领域的立场文件:当前概述与未来展望
EPMA J. 2015 Apr 15;6(1):9. doi: 10.1186/s13167-015-0030-6. eCollection 2015.
5
Future of biobanks - bigger, longer, and more dimensional.生物样本库的未来——更大、更长久且维度更多。
Croat Med J. 2013 Oct 28;54(5):496-500. doi: 10.3325/cmj.2013.54.496.
6
The clinic as a good corporate neighbor.该诊所是一个友善的企业邻居。
Croat Med J. 2013 Feb;54(1):78-82. doi: 10.3325/cmj.2013.54.78.
7
Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.癌症的预测、预防和个体化医学的多参数系统策略。
EPMA J. 2013 Jan 22;4(1):2. doi: 10.1186/1878-5085-4-2.

本文引用的文献

1
Personalized medicine and education: the challenge.个性化医疗与教育:挑战
Croat Med J. 2012 Aug;53(4):298-300. doi: 10.3325/cmj.2012.53.298.
2
Chemistry and personalized medicine - the research and development future of Europe.化学与个性化医疗——欧洲的研发未来
Croat Med J. 2012 Aug;53(4):291-3. doi: 10.3325/cmj.2012.53.291.
3
Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.Erg 和 AP-1 作为急性淋巴细胞白血病糖皮质激素反应的决定因素。
Oncogene. 2013 Jun 20;32(25):3039-48. doi: 10.1038/onc.2012.321. Epub 2012 Aug 6.
4
Personalized medicine--a tailored health care system: challenges and opportunities.个性化医疗——一种定制化的医疗保健系统:挑战与机遇
Croat Med J. 2012 Jun;53(3):211-3. doi: 10.3325/cmj.2012.53.211.
5
The promise and challenge of personalized medicine: aging populations, complex diseases, and unmet medical need.个性化医疗的前景与挑战:人口老龄化、复杂疾病及未满足的医疗需求。
Croat Med J. 2012 Jun;53(3):207-10. doi: 10.3325/cmj.2012.53.207.
6
Why another conference on personalized medicine?为什么要再举办一场关于个性化医疗的会议?
Croat Med J. 2012 Jun;53(3):205-6. doi: 10.3325/cmj.2012.53.205.
7
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.针对非小细胞肺癌细胞中的表皮生长因子受体:RNA 干扰与酪氨酸激酶抑制剂或西妥昔单抗联合的效果。
BMC Med. 2012 Mar 21;10:28. doi: 10.1186/1741-7015-10-28.
8
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma.靶向细胞信号传导:BRAF抑制及其他治疗转移性恶性黑色素瘤的方法
Dermatol Res Pract. 2012;2012:259170. doi: 10.1155/2012/259170. Epub 2011 Dec 15.
9
Clinically relevant genetic variations in drug metabolizing enzymes.药物代谢酶中的临床相关遗传变异。
Curr Drug Metab. 2011 Jun;12(5):487-97. doi: 10.2174/138920011795495321.
10
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.

个性化医疗路线图。

Roadmap to personalized medicine.

作者信息

Qattan Malak, Demonacos Constantinos, Krstic-Demonacos Marija

机构信息

Marija Krstic-Demonacos, Faculty of Life Sciences, The University of Manchester, Manchester, UK.

出版信息

Croat Med J. 2012 Aug;53(4):294-7. doi: 10.3325/cmj.2012.53.294.

DOI:10.3325/cmj.2012.53.294
PMID:22911518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3428814/
Abstract

Standard clinical protocols and the concept "one drug fits all" that are currently used to treat illness in many cases are not effective, and strikingly so in the treatment of cancer, where 75% of therapeutic schemes are ineffective. The concept of personalized medicine is that the treatment of the disease is designed on the basis of the individual needs of each patient and the factors that influence their response to different drugs. Individualization of patient care has the potential to generate novel effective therapies, limit the adverse drug effects, create optimal treatments for individual patients, and decrease the cost associated with chronic illness and complications of drug usage. However, to achieve the goals of personalized medicine many challenges must be addressed. Here we discuss possible ways to increase the consistency of data generated by basic research and their suitability for application in medicine. New technologies employing systems biology and computer based approaches will facilitate overcoming many of the scientific challenges in the field. Changes in the education of researchers, health professionals, and the public are also required to successfully implement personalized medicine as a routine in the clinic. Finally, shift of the focus away from the development of blockbuster drugs in the biopharmaceutical industry, and modifications in the legal system to accommodate novel advancements need to be considered. The joint effort of all interested parties is needed to generate an efficient roadmap that will take us rapidly and safely to effective individual treatment, which will eliminate diseases and create better health care for all.

摘要

目前在许多情况下用于治疗疾病的标准临床方案和“一刀切”的理念并不有效,在癌症治疗中尤为明显,75%的治疗方案无效。个性化医疗的理念是根据每个患者的个体需求以及影响其对不同药物反应的因素来设计疾病治疗方案。患者护理的个体化有潜力产生新的有效疗法,限制药物不良反应,为个体患者创造最佳治疗方案,并降低与慢性病和药物使用并发症相关的成本。然而,要实现个性化医疗的目标,必须应对许多挑战。在此,我们讨论提高基础研究产生的数据的一致性及其在医学中应用的适用性的可能方法。采用系统生物学和基于计算机方法的新技术将有助于克服该领域的许多科学挑战。为了在临床中成功将个性化医疗作为常规手段实施,研究人员、医疗专业人员和公众的教育也需要改变。最后,需要考虑生物制药行业将重点从开发重磅炸弹药物上转移,以及修改法律制度以适应新进展。需要所有相关方共同努力,制定一个有效的路线图,将我们迅速且安全地带向有效的个体化治疗,从而消除疾病,为所有人创造更好的医疗保健。